USPTO serial 79428025
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Cosmetics; make-up; cosmetic preparations for skin care; skin texturizers; non-medicated anti-aging skincare preparations; wrinkle removing skin care preparations; non-medicated lip care preparations; skin care creams, other than for medical use; body cream; beauty care cosmetics | ACTIVE | — |
| 005 | Dermatological pharmaceutical preparations; dermatological pharmaceutical products; injectable dermal fillers; anaesthetic preparation for injection; pharmaceutical preparations, namely, injectable dermal filler, injectable poly-l-lactic acid for use in non-surgical restorative and beauty care treatment of wrinkles fine lines, folds, scars, lips, for face and body contouring, rejuvenating the skin and stimulation of collagen production; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for the treatment of damaged skin and tissue; Dermatological pharmaceutical products for use in filling out wrinkles, folds, scars, and lips, for face and body contouring, for rejuvenating the skin and for stimulation of collagen production; Dermatological pharmaceutical products, namely, biostimulatory injectable dermal filler implant; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical treatment of wrinkles, fine lines, folds, and scars; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic treatment of lips, face, and skin; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic face and body contouring; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for use in non-surgical skin rejuvenation; Dermatological pharmaceutical products, namely, injectable poly-l-lactic acid for stimulation of collagen production; Dermatological pharmaceutical products, namely, injectable dermal implant for the treatment of wrinkles, fine lines, folds, and scars; Dermatological pharmaceutical products, namely, injectable dermal implant for restorative and aesthetic treatment of lips, face, and skin; Dermatological pharmaceutical products, namely, injectable dermal implant for restorative and aesthetic face and body contouring; Dermatological pharmaceutical products, namely, injectable dermal implant for non-surgical skin rejuvenation; Dermatological pharmaceutical products, namely injectable dermal implant for stimulation of collagen production | ACTIVE | — |
| 010 | Medical apparatus and devices, namely, injection needles for use with biostimulatory injectable dermal filler implant; Medical apparatus and devices, namely, injection needles for use with biostimulatory injectable dermal filler implant medical device; Medical apparatus and devices, namely, injection needles for use with injectable poly-l-lactic acid for use in non-surgical treatment of wrinkles, fine lines, folds, and scars; Medical apparatus and devices, namely, injection needles for use with injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic treatment of lips, face, and skin; Medical apparatus and devices, namely, injection needles for use with injectable poly-l-lactic acid for use in non-surgical restorative and aesthetic face and body contouring; Medical apparatus and devices, namely, injection needles for use with injectable poly-l-lactic acid for use in non-surgical skin rejuvenation; Medical apparatus and devices, namely, injection needles for use with injectable poly-llactic acid for stimulation of collagen production; Medical apparatus and devices, namely, injection needles for use with injectable dermal implant for the treatment of wrinkles, fine lines, folds, and scars; Medical apparatus and devices, namely, injection needles for use with injectable dermal implant for restorative and aesthetic treatment of lips, face, and skin; Medical apparatus and devices, namely, injection needles for use with injectable dermal implant for restorative and aesthetic face and body contouring; Medical apparatus and devices, namely, injection needles for use with injectable dermal implant for non-surgical skin rejuvenation; Medical apparatus and devices, namely, injection needles for use with injectable dermal implant for stimulation of collagen production; medical therapy instruments in the nature of an injection needle; hypodermic injection apparatus, namely, hypodermic needles, medical syringes and disposable syringes; hypodermic syringes for injections for medical purposes; injection needles for medical use | ACTIVE | — |
| 044 | Dermatological services for treating skin conditions; beauty consultancy; beauty treatment services of the body and face; beauty care services; beauty information services; beauty therapy treatments, namely, cosmetic body care services in the nature of cosmetic skin care services, including non-surgical treatment of fine lines and wrinkles, and the injection of dermal filling agents and neuromuscular blocking agents to reduce the appearance of facial lines and wrinkles; beauty therapy treatment services, namely, non-invasive cosmetic body care services and cosmetic face care services; beauty therapy treatment services, namely cosmetic skincare treatment services in the nature of providing an injectable dermal filler to reduce the appearance of facial fine lines; cosmetic skin care services, namely, injection of dermal filling treatment for cosmetic skin care | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 28, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 28, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 9, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 9, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 3, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 13, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 16, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 16, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 16, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 16, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 16, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 16, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 16, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 22, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 5, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 5, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 17, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 16, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 15, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 30, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 30, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 17, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |